Navigating Asia–EMA Regulatory Pathways to Accelerate Global Development
- Compare regulatory frameworks, approval pathways, and clinical trial requirements across key Asian markets and the EMA
- Identify opportunities to streamline global development by leveraging Asia’s evolving regulatory landscape
- Highlight emerging opportunities for biotechs to expand into Asian markets through collaborative or parallel regulatory approaches